Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Malignant pleural mesothelioma: a phase II trial with docetaxel.

Vorobiof DA, Rapoport BL, Chasen MR, Abratt RP, Cronje N, Fourie L, McMichael G, Hacking D.

Ann Oncol. 2002 Mar;13(3):412-5.

PMID:
11996472
[PubMed - indexed for MEDLINE]
Free Article
2.

Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group.

van Meerbeeck J, Debruyne C, van Zandwijk N, Postmus PE, Pennucci MC, van Breukelen F, Galdermans D, Groen H, Pinson P, van Glabbeke M, van Marck E, Giaccone G.

Br J Cancer. 1996 Sep;74(6):961-3.

PMID:
8826866
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Docetaxel and irinotecan (CPT-11) in the treatment of malignant pleural mesothelioma--a feasibility study.

Knuuttila A, Ollikainen T, Halme M, Mali P, Kivisaari L, Linnainmaa K, Jekunen A, Mattson K.

Anticancer Drugs. 2000 Apr;11(4):257-61.

PMID:
10898540
[PubMed - indexed for MEDLINE]
4.

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.

Fossella FV, Lee JS, Murphy WK, Lippman SM, Calayag M, Pang A, Chasen M, Shin DM, Glisson B, Benner S, et al.

J Clin Oncol. 1994 Jun;12(6):1238-44.

PMID:
7911160
[PubMed - indexed for MEDLINE]
5.

Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative Group.

Sahmoud T, Postmus PE, van Pottelsberghe C, Mattson K, Tammilehto L, Splinter TA, Planting AS, Sutedja T, van Pawel J, van Zandwijk N, Baas P, Roozendaal KJ, Schrijver M, Kirkpatrick A, Van Glabbeke M, Ardizzoni A, Giaccone G.

Eur J Cancer. 1997 Nov;33(13):2211-5.

PMID:
9470808
[PubMed - indexed for MEDLINE]
6.

Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial.

Hesketh PJ, Crowley JJ, Burris HA 3rd, Williamson SK, Balcerzak SP, Peereboom D, Goodwin JW, Gross HM, Moore DF Jr, Livingston RB, Gandara DR.

Cancer J Sci Am. 1999 Jul-Aug;5(4):237-41.

PMID:
10439170
[PubMed - indexed for MEDLINE]
7.

A phase II trial of docetaxel in advanced non-small cell lung cancer.

Saarinen A, Jekunen A, Halme M, Pyrhönen S, Tamminen K, Boyer R, Roubille N, Mattson K.

Anticancer Drugs. 1996 Nov;7(8):890-2.

PMID:
8991195
[PubMed - indexed for MEDLINE]
8.

Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma. A Minnie Pearl Cancer Research Network Phase II Trial.

Hainsworth JD, Burris HA 3rd, Litchy S, Morrissey LH, Barton JH, Bradof JE, Greco FA.

Cancer. 2000 Jul 15;89(2):328-33.

PMID:
10918162
[PubMed - indexed for MEDLINE]
9.

Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer.

Belani CP, Einzig A, Bonomi P, Dobbs T, Capozzoli MJ, Earhart R, Cohen LJ, Luketich JD.

Ann Oncol. 2000 Jun;11(6):673-8.

PMID:
10942054
[PubMed - indexed for MEDLINE]
Free Article
10.

Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.

Catimel G, Verweij J, Mattijssen V, Hanauske A, Piccart M, Wanders J, Franklin H, Le Bail N, Clavel M, Kaye SB.

Ann Oncol. 1994 Jul;5(6):533-7.

PMID:
7918125
[PubMed - indexed for MEDLINE]
11.

Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study.

Kunitoh H, Watanabe K, Onoshi T, Furuse K, Niitani H, Taguchi T.

J Clin Oncol. 1996 May;14(5):1649-55.

PMID:
8622084
[PubMed - indexed for MEDLINE]
12.

Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer.

Chevallier B, Fumoleau P, Kerbrat P, Dieras V, Roche H, Krakowski I, Azli N, Bayssas M, Lentz MA, Van Glabbeke M.

J Clin Oncol. 1995 Feb;13(2):314-22.

PMID:
7844592
[PubMed - indexed for MEDLINE]
13.

Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study.

Fizazi K, Doubre H, Le Chevalier T, Riviere A, Viala J, Daniel C, Robert L, Barthélemy P, Fandi A, Ruffié P.

J Clin Oncol. 2003 Jan 15;21(2):349-54.

PMID:
12525529
[PubMed - indexed for MEDLINE]
14.

Phase II trial of docetaxel in non-Hodgkin's lymphomas: a study of the Cancer and Leukemia Group B.

Budman DR, Petroni GR, Johnson JL, Cooper MR, Schlossman DM, Barcos M, Peterson BA.

J Clin Oncol. 1997 Oct;15(10):3275-9.

PMID:
9336365
[PubMed - indexed for MEDLINE]
15.

Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel.

Chen YM, Shih JF, Lee CS, Chen MC, Lin WC, Tsai CM, Perng RP.

Lung Cancer. 2003 Feb;39(2):209-14.

PMID:
12581575
[PubMed - indexed for MEDLINE]
16.

A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: report of the Clinical Screening Group of the EORTC.

Fumoleau P, Chevallier B, Kerbrat P, Krakowski Y, Misset JL, Maugard-Louboutin C, Dieras V, Azli N, Bougon N, Riva A, Roche H.

Ann Oncol. 1996 Feb;7(2):165-71.

PMID:
8777173
[PubMed - indexed for MEDLINE]
Free Article
17.

Phase II trial of docetaxel chemotherapy in patients with incurable adenocarcinoma of the esophagus.

Heath EI, Urba S, Marshall J, Piantadosi S, Forastiere AA.

Invest New Drugs. 2002 Feb;20(1):95-9.

PMID:
12003198
[PubMed - indexed for MEDLINE]
18.

Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B.

Kindler HL, Herndon JE, Zhang C, Green MR; Cancer and Leukemia Group B.

Lung Cancer. 2005 Jun;48(3):423-8. Epub 2005 Feb 16.

PMID:
15893012
[PubMed - indexed for MEDLINE]
19.

Japanese experience with second-line chemotherapy with low-dose (60 mg/M2) docetaxel in patients with advanced non-small-cell lung cancer.

Mukohara T, Takeda K, Miyazaki M, Takifuji N, Terakawa K, Negoro S.

Cancer Chemother Pharmacol. 2001 Nov;48(5):356-60.

PMID:
11761452
[PubMed - indexed for MEDLINE]
20.

Docetaxel in the treatment of non-small cell lung cancer: review of single-agent trials.

Fossella FV.

Semin Oncol. 1999 Oct;26(5 Suppl 16):17-23; discussion 41-2. Review.

PMID:
10585004
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk